Treatment groups included 16,417 JAKi courses, 35,373 tumor necrosis factor inhibitor courses, and 21,218 courses of biologic therapies with other mechanisms of action. Most person-time ...

Sanofi will halt the development of its oral tumour necrosis factor (TNF) inhibitor balinatunfib as ... or refraining from, any action on the basis of the content on our site.

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback ... Led by AbbVie’s Humira, biologic TNF inhibitors transformed the treatment of autoimmune diseases over ...

Explore why INmune Bio, Inc. is a speculative Strong Buy for high-risk investors. Click for the upcoming catalysts that make ...

Circle Pharma to Present Late-Breaking Data at AACR 2025 Demonstrating Mechanism of Action for Novel Cyclin A/B RxL Inhibitors Circle Pharma, a clinical-stage biopharmaceutical company focused on ...

Second, abatacept offers an alternative mechanism of action, which gives it a strong position as a second-line biologic therapy for patients who do not respond to their first TNF inhibitor.

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "RAGE Inhibitor - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report is a comprehensive resource providing ...

The poster will present new mechanistic insights into the anti-cancer activity of cyclin A/B RxL inhibitors, including their impact on DNA repair pathways and mitotic progression in E2F-high cancers.

The report elaborates on RAGE inhibitors' mechanism of action, emphasizing factors influencing market growth, including clinical trials, product development activities, mergers and acquisitions, ...

Schematic of TNF inhibitors and their mode of action. Receptor (i.e. etanercept, lenercept) and antibody based (i.e. infliximab, adalimumab, golimumab) anti-TNF biologics inhibit both solTNF and ...